Riskpilot← Back to searchSign inGet full accessDerma Clinic Älvsjö AB
ABActiveOrg 5590976048Älvsjötorget 15 BMedical specialists activities · NACE 8622Est. 20175-9 employees
Revenue 2024
SEK 3,6M
+14% vs 2023
EBITDA margin
-8.4%
-206% vs 2023
Equity ratio
43.2%
Financial strength
Net profit 2024
SEK 23K
-89% vs 2023
| Revenue | SEK 3,6M | +14% |
| EBITDA | SEK -305K | -206% |
| Net profit | SEK 23K | -89% |
| Total assets | SEK 1,2M | -9% |
| Equity | SEK 507K | +5% |
| Employees | — | — |
Legal name
Derma Clinic Älvsjö AB
Org number
5590976048
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
18 januari 2017
Share capital
SEK 50 000
Employees
5-9
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva hälso- och sjukvård med specialisering på vård, hudsjukvård, hudvård och därmed förenlig verksamhet.
Address
Älvsjötorget 15 B
Email
killasli@yahoo.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 4 500 | 5 212 | 2 890 | 3 189 | 3 631 |
| Staff expenses | — | — | −737 | −704 | −1 124 |
| EBITDA | 124 | 1 181 | 87 | 289 | −305 |
| Depreciation & amort. | −51 | −59 | −52 | −30 | −25 |
| EBIT | 73 | 1 122 | 35 | 259 | −330 |
| Net financials | — | — | −1 | −1 | 3 |
| Profit before tax | 72 | 852 | 35 | 258 | 33 |
| Tax | −16 | −176 | −9 | −58 | −11 |
| Net profit | 56 | 676 | 26 | 200 | 23 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 417 | 2 161 | 977 | 1 293 | 1 174 |
| Equity | 582 | 1 258 | 284 | 484 | 507 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 744 | 543 | 333 | 449 | 667 |
| Total debt | 744 | 543 | 333 | 449 | 667 |
EBITDA margin
-8.4%
This company
15.8%
Market median
-153% vs market
20202024
Equity ratio
43.2%
This company
38.2%
Market median
+13% vs market
20202024
Return on equity
4.5%
This company
18.4%
Market median
-76% vs market
20202024
Net profit margin
0.6%
This company
8.1%
Market median
-93% vs market
20202024
Asset turnover
3.09×
This company
1.12×
Market median
+176% vs market
20202024
Debt / equity
1.32×
This company
0.62×
Market median
-113% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
IL Chief Executive Officer | Chief Executive Officer | 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2025 | |
| Former (1) | ||
| Board of Directors | 2022 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Derma Clinic Älvsjö AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Inga Louise Lönndahl | Chief Executive Officer | 0 companies |
| Hassan Killasli | Board of Directors | 0 companies |
| Adam Nezar Killasli | Deputy Board Member | 0 companies |